Thus, this finding concluded that the antioxidant activity of SNE could act directly to these free radical scavenging enzymes at their transcriptional modification process and might subsequently modulate other cellular proteins to ameliorate hyperglycemia, hyperlipidemia, insulin resistance, and Oat3 regulatory function.
Green tea catechins inhibit cancer development of modulating key cellular proteins involved in numerous signal transduction pathways and thus altering the function of genes involved in cell proliferation, invasion, angiogenesis, and apoptosis [ 5, 6].
Consequently, even a small canopy exposure suffices to modulate some abundant cellular proteins; 27% of these proteins were changed when only one leaf was UV-B-irradiated.
Given the ability of miRNAs to modulate cellular mRNAs and proteins and thus cellular physiology, we identified a critical neuronal transcription factor, myocyte enhancer factor 2C (MEF2C), as a target of miR-21.
Thus, apoptosis is also modulated by additional cellular proteins which in general are not known.
Thus, we utilized heparin-based microparticles to modulate cellular differentiation via protein sequestration in an in vitro model system of endochondral ossification.
In addition to the proteins that are required for basic viral functions like replication and morphogenesis, numerous ASFV proteins modulate cellular pathways like apoptosis or innate immunity, accounting for the high complexity of virus-host interactions7.
Therefore, we sought to investigate whether interactions between host signaling pathways and the NF-κB regions of different HIV-1 subtypes, together with subtype-specific interactions between Tat, TAR, and cellular proteins, modulate the efficiency of HIV-1 clade-specific gene transcription.
Scaffold proteins modulate cellular signaling by facilitating assembly of specific signaling pathways.
The feature that p53 and MMR proteins modulate cellular responses upon DNA damage and the availability of genetically engineered human and murine cells present a potential means to develop strategies to circumvent the reduced responsiveness by re-sensitising or by hypersensitising p53-mutant tumours to therapeutic regimens.
